An official website of the United States Government -

January 2016 Public Meeting

The January 2016 MACPAC public meeting opened with a review of the March 2016 report to Congress draft chapter on the affordability of children’s coverage. The draft chapter compares out-of-pocket spending for children under exchange coverage to separate State Children’s Health Insurance Programs (CHIP) in 36 states. It was followed by a new analysis comparing low- and moderate-income families’ out-of-pocket spending for employer-sponsored insurance with their out-of-pocket costs for separate CHIP programs. The Commission then began a discussion of how it will get to a package of recommendations on children’s coverage by the end of 2016.

The afternoon presentations began with the continuation of a discussion—initiated in October 2015—of functional assessment tools that states use both to determine eligibility and develop care plans for Medicaid long-term services and supports. That session was followed by a discussion of measures of provider participation in Medicaid using information from claims and encounter data. Next on the agenda were two sessions on Medicaid reform, one reviewing past proposals from presidents’ budgets, Medicaid commissions, governors’ associations, and think tanks, and the other addressing alternative financing approaches and related policy and technical issues.

The meeting concluded with a presentation on the Centers for Medicare & Medicaid Services’ long-anticipated final rule on Medicaid-covered outpatient drugs.


  1. Design Considerations for the Future of Children’s Coverage: Focus on Affordability
  2. Affordability for Children in Separate CHIP Versus Employer-Sponsored Insurance
  3. MACPAC’s Work on Children’s Coverage and Next Steps
  4. Functional Assessments for Long-Term Services and Supports: Part 2
  5. Providers Serving Medicaid Patients
  6. Historical Review of Proposals to Reform Medicaid
  7. Addressing Growth in Federal Medicaid Spending: Selected Financing Alternatives
  8. Medicaid Outpatient Drug Rule